Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
2 studies found for:    17881719 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Enrolling by invitation A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
Condition: Parkinson Disease
Intervention:
2 Terminated Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
Condition: Parkinson Disease
Interventions: Drug: CEP-1347 10mg;   Drug: CEP1347 25mg;   Drug: CEP-1347 50mg;   Other: Placebo Comparator
To Top

† Indicates status has not been verified in more than two years